Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/12644542

J. Natl. Cancer Inst. 2003 Mar 19 95 6 484-6

Download in:

View as

Triples

General Info

PMID
12644542